Identification of target and pathway of aspirin combined with Lipitor treatment in prostate cancer through integrated bioinformatics analysis

Our previous studies have confirmed that aspirin combined with Lipitor inhibited the development of prostate cancer (PCa), but the mechanisms need to be comprehensively expounded. The study aims to screen out the hub genes of combination therapy and to explore their association with the pathogenesis...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Toxicology and applied pharmacology 2022-10, Vol.452, p.116169-116169, Article 116169
Hauptverfasser:	Wang, Xiao, Wu, Yi, Liu, Junlei, Xu, Xuetao, Sheng, Zhaojun, Liu, Wenfeng, Chen, Min, Ma, Yanyan, Zhao, Denggao, Li, Dongli, Zheng, Xi
Format:	Artikel
Sprache:	eng
Schlagworte:	Aspirin DNA replication and sister chromatid cohesion 1 Lipitor Prostate cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!